FR2392008A1 - Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs - Google Patents

Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs

Info

Publication number
FR2392008A1
FR2392008A1 FR7713478A FR7713478A FR2392008A1 FR 2392008 A1 FR2392008 A1 FR 2392008A1 FR 7713478 A FR7713478 A FR 7713478A FR 7713478 A FR7713478 A FR 7713478A FR 2392008 A1 FR2392008 A1 FR 2392008A1
Authority
FR
France
Prior art keywords
ester
active acid
pharmaceutically active
enhanced activity
pyridine carboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713478A
Other languages
English (en)
Other versions
FR2392008B1 (fr
Inventor
Silvano Casadio
Henri Cousse
Gilbert Mouzin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7713478A priority Critical patent/FR2392008A1/fr
Publication of FR2392008A1 publication Critical patent/FR2392008A1/fr
Application granted granted Critical
Publication of FR2392008B1 publication Critical patent/FR2392008B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux vecteurs choisis parmi les N-hydroxy alcoyl pyridine carboxamides permettant d'obtenir par estérification avec des acides thérapeutiquement actifs de nouvelles formes modulées de médicaments. Les composés chimiques répondent aux formules générales :
FR7713478A 1977-05-02 1977-05-02 Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs Granted FR2392008A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7713478A FR2392008A1 (fr) 1977-05-02 1977-05-02 Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7713478A FR2392008A1 (fr) 1977-05-02 1977-05-02 Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs

Publications (2)

Publication Number Publication Date
FR2392008A1 true FR2392008A1 (fr) 1978-12-22
FR2392008B1 FR2392008B1 (fr) 1980-08-29

Family

ID=9190295

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713478A Granted FR2392008A1 (fr) 1977-05-02 1977-05-02 Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs

Country Status (1)

Country Link
FR (1) FR2392008A1 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476072A1 (fr) * 1980-02-18 1981-08-21 Fabre Sa Pierre Phenyl-4 benzoate de nicotinamido methyle, nouveaux derives utiles en therapeutique comme normolipemiants choleretiques
EP0161422A1 (fr) * 1984-03-21 1985-11-21 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Dérivés d'alkanolamines et inhibiteurs d'agrégation de plaquettes contenant ces dérivés comme ingrédients actifs
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
WO2010009212A1 (fr) * 2008-07-17 2010-01-21 Schering Corporation Dérivés de niacine utiles pour traiter des syndromes métaboliques
WO2010009210A2 (fr) * 2008-07-17 2010-01-21 Schering Corporation Dérivés d'acide acétylsalicylique utiles pour traiter des syndromes métaboliques
US7736624B2 (en) 2006-06-19 2010-06-15 Univ Vanderbilt Methods and compositions for diagnostic and therapeutic targeting of COX-2
US8168656B2 (en) 2004-04-26 2012-05-01 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
US9346803B2 (en) 2011-10-17 2016-05-24 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476072A1 (fr) * 1980-02-18 1981-08-21 Fabre Sa Pierre Phenyl-4 benzoate de nicotinamido methyle, nouveaux derives utiles en therapeutique comme normolipemiants choleretiques
EP0161422A1 (fr) * 1984-03-21 1985-11-21 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Dérivés d'alkanolamines et inhibiteurs d'agrégation de plaquettes contenant ces dérivés comme ingrédients actifs
US4619938A (en) * 1984-03-21 1986-10-28 Terumo Kabushiki Kaisha Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet aggregation inhibitors
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6399647B2 (en) 1999-01-07 2002-06-04 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
US8168656B2 (en) 2004-04-26 2012-05-01 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
US7736624B2 (en) 2006-06-19 2010-06-15 Univ Vanderbilt Methods and compositions for diagnostic and therapeutic targeting of COX-2
US8143302B2 (en) 2006-06-19 2012-03-27 Vanderbilt University Methods and compositions for diagnostic and therapeutic targeting of COX-2
US8865130B2 (en) 2006-06-19 2014-10-21 Vanderbilt University Methods and compositions for diagnostic and therapeutic targeting of COX-2
WO2010009210A2 (fr) * 2008-07-17 2010-01-21 Schering Corporation Dérivés d'acide acétylsalicylique utiles pour traiter des syndromes métaboliques
WO2010009210A3 (fr) * 2008-07-17 2010-06-03 Schering Corporation Dérivés d'acide acétylsalicylique utiles pour traiter des syndromes métaboliques
WO2010009212A1 (fr) * 2008-07-17 2010-01-21 Schering Corporation Dérivés de niacine utiles pour traiter des syndromes métaboliques
US9346803B2 (en) 2011-10-17 2016-05-24 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
US9895351B2 (en) 2011-10-17 2018-02-20 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
US10398678B2 (en) 2011-10-17 2019-09-03 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
US11738004B2 (en) 2011-10-17 2023-08-29 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer

Also Published As

Publication number Publication date
FR2392008B1 (fr) 1980-08-29

Similar Documents

Publication Publication Date Title
NZ186741A (en) 4-(5-halomethyl-2-pyridyloxy)-phenoxyalkane carboxylic acids and derivatives; herbicidal compositions
JPS53112881A (en) Substituted pyridylmethyl ester of cyclopropanee carboxylic acid
LU79281A1 (fr) Procede de preparation de terpolymeres d'anhydride maleique et leur application comme agents anti-tartre
FR2392008A1 (fr) Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs
BE838642A (fr) Utilisation de perfluoroalcane-sulfonamides et/ou de sels d'ammonium et/ou de cyclimmonium d'acides perfluoroalcane-sulfoniques comme agents de demoulage
JPS54106448A (en) N alphaaalkylsulfonyl omegaaamidinophenyll alphaaaminoalkyl carboxylic acid amide and n alphaaamidinophenyllalphaaaminoalkyl carboxilic amide
BE853258A (fr) Nouveaux derives d'amides d'acides carboxyliques n-substitues a action hypoglycemiante et (ou) hypolipidemiante leur preparation et leur utilisation
FR2330398A1 (fr) Esters d'acides 3-aminomethylene-6,7-dimethoxy-2 -methyl-4 -oxo-1,2,3,4- tetrahydro-1- quinoleine carboxyliques et intermediaires y conduisant
ATA917478A (de) Herstellung des neuen n-(5-methoxybenzofuran-2-yl-carbonyl)n'-benzylp perazins oder dessen saeure- additionssalzen
SE7808060L (sv) Forfarande for framstellning av n-substituerade alfa-ketokarboxylsyraamider
FR2302999A1 (fr) Esters bromophenyliques d'acides aryl-sulfoniques, leur obtention et leur utilisation comme agents retardateurs de combustion
BE868590A (fr) Derives alpha-acetyleniques et alpha-vinyliques d'amino-acides
FR2363541A1 (fr) Acyloxy-n,n' diacylmalonamides et leur mode de preparation
JPS54103874A (en) 44hydroxyyisophthalic acid picolyl amide and medical composition
BE859290A (fr) Preparation d'acides alpha-cetocarboxyliques aliphatiques et heterocycliques
JPS5436262A (en) Alphaahalomethyl derivative of amino acid
IT1157378B (it) Procedimento per produrre poliammidi mediante polimerizzazione di lattami e prodotti cosi' ottenuti
DE2860399D1 (en) Process for preparing 3,5:4,6- protected derivatives of l- or d- gulonic acid, their use in preparing 2- keto-l- or d- gulonic acid or their esters or l- or d- ascorbic acid, and certain novel 2-nitrato-gulonate intermediates
IT1164131B (it) Composti di acido mercaptoacilpiperazin carbossilico e relativi salidotati di attivita' farmacologica come agenti ipotensivi
TR20027A (tr) O-fenilditiofosfonik asid esterleri,imallerine mahsus usuller ve ensektisidler,akarisidler ve nematisidler olarak kullanilmalari
JPS54122217A (en) Manufacture of nnsubstituted carboxylic acid amide
BE871745A (fr) Procede d'amelioration des proprietes des gruaux et farines de graines oleagineuses
PH13389A (en) Substituted n-(phenyl)-dithiocarbamic acid ester,pharmaceutical compositions and method of using same
BE849389A (fr) Sels de derives du 2,4-diaminoazobenzene et d'acides alkylarene-sulfoniques, leur preparation et leur utilisation comme colorants
HU175527B (hu) Sposob dlja totalsinteze slozhnykh efirov apovinkaminnojj kisloty i gomologov

Legal Events

Date Code Title Description
ST Notification of lapse